Pei-Chin Tsai
Overview
Explore the profile of Pei-Chin Tsai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
159
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hu C, Chen C, Tsai H, Lei H, Le H, Tsou Y, et al.
J Chin Med Assoc
. 2025 Jan;
88(3):222-230.
PMID: 39838516
Background: ABO-incompatible liver transplantation (ABOi LT) can now be successfully performed using standard pretransplant induction therapy. ABOi LT can achieve long-term outcomes comparable to those of blood type-compatible (ABOc) LT....
2.
Adeleke O, Tsai P, Karry K, Monama N, Michniak-Kohn B
Int J Pharm
. 2018 Jun;
547(1-2):347-359.
PMID: 29879506
Drug treatment remains the most effective global approach to managing and preventing tuberculosis. This work focuses on formulating and evaluating an optimized polyvinyl alcohol-polyethylene glycol based orodispersible strip containing isoniazid,...
3.
Hsu J, Tang P, Wang I, Liu C, Chen W, Tsai P, et al.
Proc Natl Acad Sci U S A
. 2016 Mar;
113(12):E1683-90.
PMID: 26966233
ADP ribosylation factor (Arf) GTPases are key regulators of membrane traffic at the Golgi complex. In yeast, Arf guanine nucleotide-exchange factor (GEF) Syt1p activates Arf-like protein Arl1p, which was accompanied...
4.
Adeleke O, Monama N, Tsai P, Sithole H, Michniak-Kohn B
Mol Pharm
. 2015 Dec;
13(2):456-71.
PMID: 26650101
To date, effective treatment, prophylaxis, and control of tuberculosis (TB) infection is mainly dependent on the use of drugs. However, patient noncompliance with prescribed anti-TB treatment schemes remains a major...
5.
Tsai P, Lee S, Michniak-Kohn B
Ther Deliv
. 2015 Oct;
6(9):1043-52.
PMID: 26419344
This article provides a review of the critical in vitro assays utilized in transdermal drug development. In vitro assays such as percutaneous absorption testing and dissolution (drug release) testing are...
6.
Tsai P, Zhang Z, Florek C, Michniak-Kohn B
Tissue Eng Part A
. 2015 Sep;
22(1-2):111-22.
PMID: 26415037
The irritancy of topical products has to be investigated to ensure the safety and compliance. Although several reconstructed human epidermal models have been adopted by the Organization for Economic Cooperation...
7.
Zhang Z, Tsai P, Ramezanli T, Michniak-Kohn B
Wiley Interdiscip Rev Nanomed Nanobiotechnol
. 2013 Feb;
5(3):205-18.
PMID: 23386536
Human skin not only functions as a permeation barrier (mainly because of the stratum corneum layer) but also provides a unique delivery pathway for therapeutic and other active agents. These...
8.
Tsai P, Hsu J, Liu Y, Chen K, Lee F
Proc Natl Acad Sci U S A
. 2013 Jan;
110(8):E668-77.
PMID: 23345439
ADP ribosylation factors (Arfs) are the central regulators of vesicle trafficking from the Golgi complex. Activated Arfs facilitate vesicle formation through stimulating coat assembly, activating lipid-modifying enzymes and recruiting tethers...
9.
Chen K, Tsai P, Liu Y, Lee F
J Cell Sci
. 2012 Jul;
125(Pt 19):4586-96.
PMID: 22767516
Golgins play diverse roles in regulating the structure and function of the Golgi. The yeast golgin Imh1p is targeted to the trans-Golgi network (TGN) through interaction of its GRIP domain...
10.
Elangovan S, Jain S, Tsai P, Margolis H, Amiji M
J Periodontol
. 2012 Mar;
84(1):117-25.
PMID: 22414259
Background: Growth factors such as platelet-derived growth factor (PDGF) have significantly enhanced periodontal therapy outcomes with a high degree of variability, mostly due to the lack of continual supply for...